Repligen
RGEN
#2045
Rank
NZ$16.07 B
Marketcap
NZ$285.58
Share price
-0.47%
Change (1 day)
18.08%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$1.45 Billion

According to Repligen 's latest financial reports the company's total liabilities are NZ$1.45 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.51 B10.92%
2023-12-31NZ$1.36 B40.08%
2022-12-31NZ$0.97 B9.81%
2021-12-31NZ$0.89 B71.93%
2020-12-31NZ$0.51 B2.5%
2019-12-31NZ$0.50 B113.12%
2018-12-31NZ$0.23 B10.81%
2017-12-31NZ$0.21 B23.37%
2016-12-31NZ$0.17 B405.4%
2015-12-31NZ$34.31 M62.37%
2014-12-31NZ$21.13 M17.69%
2013-12-31NZ$17.95 M14.66%
2012-12-31NZ$15.66 M
2011-03-31NZ$6.84 M-8.58%
2010-03-31NZ$7.48 M-8.33%
2009-03-31NZ$8.16 M38.75%
2008-03-31NZ$5.88 M19.08%
2007-03-31NZ$4.94 M-5.5%
2006-03-31NZ$5.23 M12.18%
2005-03-31NZ$4.66 M27.01%
2004-03-31NZ$3.67 M-9.38%
2003-03-31NZ$4.05 M-33.04%
2002-03-31NZ$6.05 M91.2%
2001-03-31NZ$3.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
NZ$2.31 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.69 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$2.18 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$189.06 B 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$89.78 B 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.51 B 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.96 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.14 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$7.03 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA